Early knowledge propose this duo may perhaps surpass Ozempic® (semaglutide) in both velocity and magnitude of outcomes.Medical trials have revealed semaglutide to get a more practical hypoglycemic and insulinogenic agent than liraglutide most often. It demonstrates higher reductions in both